Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

2.

Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.

Kimura H, Yamamoto N, Shirai T, Nishida H, Hayashi K, Tanzawa Y, Takeuchi A, Igarashi K, Inatani H, Shimozaki S, Kato T, Aoki Y, Higuchi T, Tsuchiya H.

Cancer Med. 2015 Mar;4(3):333-41. doi: 10.1002/cam4.373. Epub 2014 Dec 23.

3.

A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.

Hsu ES.

Am J Ther. 2010 Sep-Oct;17(5):476-86. doi: 10.1097/MJT.0b013e3181ea7821. Review.

PMID:
20844345
5.
6.

Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.

Aksoylar S, Akman SA, Ozgenç F, Kansoy S.

Pediatr Hematol Oncol. 2001 Sep;18(6):397-406.

PMID:
11554235
8.

Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Phillips RS, Friend AJ, Gibson F, Houghton E, Gopaul S, Craig JV, Pizer B.

Cochrane Database Syst Rev. 2016 Feb 2;2:CD007786. doi: 10.1002/14651858.CD007786.pub3. Review.

PMID:
26836199
10.

Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based Chemotherapy.

Kaito D, Iihara H, Funaguchi N, Endo J, Ito F, Yanase K, Toyoshi S, Sasaki Y, Hirose C, Arai N, Kitahora M, Ohno Y, Itoh Y, Minatoguchi S.

Anticancer Res. 2017 Apr;37(4):1965-1970.

PMID:
28373467
12.

[Prophylaxis of chemotherapy-induced vomiting and nausea].

Tóth J, Szántó J.

Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Review. Hungarian.

PMID:
19068468
13.
16.
17.

Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.

Babaoglu MO, Bayar B, Aynacioglu AS, Kerb R, Abali H, Celik I, Bozkurt A.

Clin Pharmacol Ther. 2005 Dec;78(6):619-26.

PMID:
16338277
18.

Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial.

Panahi Y, Saadat A, Sahebkar A, Hashemian F, Taghikhani M, Abolhasani E.

Integr Cancer Ther. 2012 Sep;11(3):204-11. doi: 10.1177/1534735411433201. Epub 2012 Feb 7.

PMID:
22313739
19.

5-HT3 antiemetic therapy for patients with breast cancer.

Perez EA.

Breast Cancer Res Treat. 1999 Sep;57(2):207-14. Review.

PMID:
10598048

Supplemental Content

Support Center